Clemens A. Schmitt

Kepler Universitätsklinikum — Austria

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index16.0kcitations317works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(51), CRISPR and Genetic Engineering(45), Telomeres, Telomerase, and Senescence(43), CAR-T cell therapy research(41), Genetics, Bioinformatics, and Biomedical Research(37)

Publications317 total

Abstract PS2-04-08: Incidence of second primary tumors and second primary breast cancers events in patients with metastatic breast cancer: results from the Austrian AGMT_MBC-Registry
Clinical Cancer Research·2026
Abstract PS1-11-26: Esr1 mutations and use of the oral serd elacestrant in metastatic breast cancer patients in austria: results from the agmt_mbc-registry
Clinical Cancer Research·2026
Translucency of <scp>3D</scp> ‐Printed <scp>3Y</scp> ‐ and <scp>5Y</scp> ‐Doped Zirconia
Journal of Esthetic and Restorative Dentistry·2025Open Access
Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
Leukemia & lymphoma/Leukemia and lymphoma·2025
lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A/RAP1 activation
Cellular & Molecular Biology Letters·2025Open Access
Therapy-induced senescence reprograms non-M3 AML into a drug-exploitable APL-like state
Blood·2025Open Access
Time-dependent long short-term memory neural cox regression in 2,690 patients with myeloid neoplasias treated with diverse therapies identifies bone marrow related information to be less important than expected in the context of other available clinical parameters: Insights from the AML-001 trial (NCT01074047) and the austrian myeloid registry (NCT04438889) of the AGMT study group
Blood·2025
Multivariable-adjusted validation of IWG23-defined peripheral blood complete remission (PB-CR) and IWG23 response criteria in 2,042 patients with MDS, CMML or AML treated with diverse first-line therapies: Insights from the AML-001 trial (NCT01074047) and the ‘austrian myeloid registry’ (NCT04438889) of the AGMT study group
Blood·2025
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
iScience·2025Open Access
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
iScience·2025Open Access
Supplemental Figure S2 from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025Open Access
Supplemental Figure S4 from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025Open Access
Data from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025· 1 citedOpen Access
Supplemental Figure S3 from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025Open Access
Supplemental Figure S1 from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025Open Access
Supplemental Figure S5 from Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression
2025Open Access
Abstract P4-12-09: Cytotoxic treatment and survival after CDK4/6 inhibitors in patients with luminal metastatic breast cancer before the era of anti-body-drug-conjugates: Results from the Austrian AGMT_MBC-Registry
Clinical Cancer Research·2025
Abstract P5-12-07: Increase of repeated biopsies in metastatic breast cancer over time: Results from the Austrian AGMT_MBC-Registry
Clinical Cancer Research·2025
477 | LONGITUDINAL MULTI‐OMICS INVESTIGATION IN IBRUTINIB‐BORTEZOMIB‐R‐CHOP‐TREATED DLBCL PATIENTS
Hematological Oncology·2025Open Access
159 | R‐POLA‐GLO – CHEMO‐LIGHT FRONTLINE THERAPY INDUCES HIGH RESPONSE RATES WITH A FAVORABLE SAFETY PROFILE IN ELDERLY/FRAIL PATIENTS WITH AGGRESSIVE LYMPHOMA
Hematological Oncology·2025· 3 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Soyoung Lee(15), Bernd Dörken(12), Maurice Reimann(11), Scott W. Lowe(10), Yong Yu(7), Maja Milanovic(6), Dido Lenze(6), Christoph Loddenkemper(5), Michael Hummel(5), Jan R. Dörr(4), Roland Eils(4), Philipp Lohneis(4), Andreas Rosenwald(4), Jesús Gil(3), Laura J. Niedernhofer(3), Dorothy Ngo-Yin Fan(3), Dimitri Belenki(3), Daniel Noerenberg(3), Mareike Frick(3), Frédérik Damm(3)